Nearly 100 new HIV treatments are in development, PhRMA says

WASHINGTON Nearly 100 new drugs are in development as treatments and vaccines for HIV, according to a new report from an organization representing the nation’s drug manufacturers.

The Pharmaceutical Research and Manufacturers of America released a report recently showing 97 products in development, including 54 antivirals and 23 vaccines, all in clinical trials or awaiting Food and Drug Administration approval.

“We are greatly encouraged by these critically important medicines and vaccines in development to treat and prevent HIV infection,” PhRMA president and CEO Billy Tauzin said in a statement. “Pharmaceutical researchers are continuing their efforts to develop new therapies and vaccines to improve and lengthen the lives of HIV-infected patients.”